Prof. Dr. Michael Lanzer
Department of Infectious Diseases, Parasitology Heidelberg University Medical School 69120 Heidelberg, Germany Phone: +49-(0)6221-56 7845 Fax: +49-(0)6221-56 4643 E-mail: michael.lanzer@med.uni-heidelberg.de
CURRICULUM VITAE
2000
Offer for Professorship at the Seattle Biomedical Institute, USA (declined)
Full Professor and Head of Department of Parasitology, University of
Habilitation in Microbiology, University of Würzburg
Junior Group Leader, Research Center for Infectious Diseases, University
Postdoc, Sloan-Kettering Institute, New York, USA.
PhD, Center for Molecular Biology, University of Heidelberg
Diploma Thesis, Hoffman LaRoche und Co. AG, Basel, Switzerland
Biology School, University of Heidelberg
COORDINATING FUNCTIONS
2005 – 2009
Member of the Executive Committee of the Marie-Curie Fellowship
Member of the Executive Committee of the Network of Excellence
Member of the Executive Committee of the European Malaria Graduate
Co-chairman of the SFB 544 “Control of Tropical Infectious Diseases”
Coordinator of various EU-funded research networks (6 in total)
HONORS 1995
Prize for Tropical Medicine, Awarded by the German Society for Tropical
FIELDS OF INTEREST
Molecular Parasitology, drug resistance mechanisms of the malarial parasite; antigenic variation, cytoadherence, protein trafficking in P. falciparum, membrane transport processes: CURRENTLY FUNDED PROJECTS
SFB544, project B12; EU-funded Network of Excellence EVIMalaR; EU-funded Integrated Project AntiMal; EU-funded Marie Curie Fellowship Program InterMalTraining; EU-funded infrastructure project Infravec, EU-funded Coordination and Support Action CRIMALDDI; EU- funded Collaborative Project PreMalStruct; DFG-project on protein trafficking in Plasmodium falciparum. PUBLICATIONS (10 most important publications):
Rotmann A, Sanchez CP, Guigemde A, Rohrbach P, Dave A, Bakouh N, Planelles G, Lanzer M (2010) PfCHA is a mitochondrial divalent cation/H+ antiporter in Plasmodium falciparum. Mol Microbiol in press.
Kuhn Y, Sanchez CP, Ayoub D, Saridaki T, van Dorsselaer A, Lanzer M (2010) Trafficking of the phosphoprotein PfCRT to the digestive vacuolar membrane in Plasmodium falciparum. Traffic 11: 236-249.
Saridaki T, Frohlich KS, Braun-Breton C, Lanzer M (2009) Export of PfSBP1 to the Plasmodium falciparum Maurer's clefts. Traffic 10: 137-152.
Saridaki T, Sanchez CP, Pfahler J, Lanzer M (2008) A conditional export system provides new insights into protein export in Plasmodium falciparum-infected erythrocytes. Cell Microbiol 10: 2483-2495.
Sanchez CP, Rotmann A, Stein WD, Lanzer M (2008a) Polymorphisms within PfMDR1 alter the substrate specificity for anti-malarial drugs in Plasmodium falciparum. Mol Microbiol 70: 786-798.
Sanchez CP, Stein WD, Lanzer M (2008b) Dissecting the components of quinine accumulation in Plasmodium falciparum. Mol Microbiol 67: 1081-1093.
Kuhn Y, Rohrbach P, Lanzer M (2007) Quantitative pH measurements in Plasmodium falciparum-infected erythrocytes using pHluorin. Cell Microbiol 9: 1004-1013.
Sanchez CP, Rohrbach P, McLean JE, Fidock DA, Stein WD, Lanzer M (2007) Differences in trans-stimulated chloroquine efflux kinetics are linked to PfCRT in Plasmodium falciparum. Mol Microbiol 64: 407-420.
Rohrbach P, Sanchez CP, Hayton K, Friedrich O, Patel J, Sidhu AB, Ferdig MT, Fidock DA, Lanzer M (2006) Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum. EMBO J 25: 3000-3011.
Przyborski JM, Miller SK, Pfahler JM, Henrich PP, Rohrbach P, Crabb BS, Lanzer M (2005) Trafficking of STEVOR to the Maurer's clefts in Plasmodium falciparum-infected erythrocytes. EMBO J 24: 2306-2317.
Lo studio morfologico della pelvi femminile ePartendo da queste semplici constatazioni ana-soprattutto quello delle ovaie ha molto beneficiatotomiche, si può preconizzare una classificazionedei progressi dell’imaging moderno. Nella diagno-più moderna dei problemi dell’ovulazione, descri-stica di un problema dell’ovulazione, l’ecografiavendo schematicamente due grandi tipi di patol
INCONTINENCE This briefing is produced as part of the Building Community Capacity Project by AVDC’s Lynne Maddocks. Contact on 01296 585364 or lmaddocks@aylesburyvaledc.gov.uk for more information. AgeUKIG15 Incontinence = a persistent problem with controlling your bladder or bowel. Urinary incontinence is a distressing condition which affects more than 2.5 million people over 60 in
Prof. Dr. Michael Lanzer